As in “chemo.”
I met with my oncologist and transplant surgeon on Tuesday to review my latest PET scan. A few areas of concern on my previous scan cleared up but a few lymph nodes are showing low-grade activity. There’s nothing large enough to biopsy or to give a clear diagnosis, but to be proactive I’m starting a four-week course of chemo next Thursday.
This will be with a the latest wonder-drug—Rituxan, which I’ve had before. It has minimal side effects other than making me a little more vulnerable to infection.
Rituxan is a “monoclonal antibody” that targets only specific cells, hence it is less toxic to healthy tissue. Rituxan focuses on a protein called CD20 located on the surface of B-cells. It stimulates the immune system to eliminate the CD20-positive, cancerous B-cells.
In six months I’ll repeat the Rituxan regime and get another scan. Hopefully it will be clean for Christmas.